Performance analysis of Corvus Pharmaceuticals (CRVS)
Annual Return
Over the past 3 years, CRVS has had an average annual return of +72.60%, outperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, CRVS has had an average annual return of +43.25%, outperforming the benchmark SPY, which returned +12.78% annual.
Over the past 10 years, CRVS has had an average annual return of -0.01%, underperforming the benchmark SPY, which returned +14.91% annual.
Since Mar 23, 2016, CRVS has had an average annual return of -0.10%, underperforming the benchmark SPY, which returned +15.20% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +83.11% | +43.95% | +203.97% | +107.21% | -64.75% | -32.31% | -34.57% | +48.27% | -64.58% | -27.55% | +0.35% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +168.80% | -11.79% | -19.88% | +3.83% | -18.30% | +20.38% | -5.62% | +83.11% | |||||
| 2025 | +0.19% | -24.62% | -21.27% | +12.86% | +5.32% | +5.80% | +4.24% | +37.66% | +28.40% | +9.09% | +14.06% | -16.02% | +43.95% |
| 2024 | +13.68% | +11.97% | -20.55% | -12.89% | +39.34% | -15.77% | +41.27% | +74.28% | +17.84% | +67.45% | +2.82% | -41.15% | +203.97% |
| 2023 | -3.52% | -10.96% | +24.80% | +18.62% | +181.40% | -24.66% | -1.74% | -5.76% | -31.12% | -22.63% | +35.44% | +14.99% | +107.21% |
| 2022 | -25.31% | -1.66% | -7.33% | -20.16% | -21.33% | -3.87% | -11.08% | +8.90% | -14.71% | +5.92% | +7.57% | -8.87% | -64.75% |
| 2021 | +4.52% | -6.47% | -11.51% | -8.42% | -2.83% | -2.55% | -21.72% | +8.11% | +114.12% | -6.39% | -24.72% | -29.34% | -32.31% |
| 2020 | +1.47% | -37.69% | -38.65% | +15.12% | +41.99% | -21.15% | +55.84% | -10.59% | +5.79% | -1.24% | +0.76% | -10.79% | -34.57% |
| 2019 | +8.74% | +21.29% | -16.93% | +5.21% | -10.85% | -0.79% | +4.53% | -12.79% | -11.74% | +10.65% | -8.43% | +78.41% | +48.27% |
| 2018 | -18.72% | -2.74% | +40.79% | -16.73% | +43.02% | -20.03% | -10.11% | +11.05% | -21.71% | -11.54% | -21.22% | -38.63% | -64.58% |
| 2017 | -1.26% | +1.84% | +44.44% | -52.19% | +2.32% | +19.09% | +1.07% | +32.22% | -1.42% | -14.80% | -17.45% | -7.59% | -27.55% |
Drawdown analysis of Corvus Pharmaceuticals (CRVS)
The maximum drawdown for the CRVS was -96.97%, occurring on Mar 28, 2023. Recovery took 705 trading sessions.
The current CRVS drawdown is -44.75%.
Since Mar 23, 2016 CRVS has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 5 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.97% | Mar 27, 2017 | 1511 | Mar 28, 2023 | 705 | Jan 20, 2026 | 2216 |
| -56.42% | Jan 22, 2026 | 93 | Jun 5, 2026 | Ongoing | Ongoing | Ongoing |
| -35.23% | Apr 15, 2016 | 19 | May 12, 2016 | 84 | Sep 12, 2016 | 103 |
| -20.92% | Oct 5, 2016 | 20 | Nov 2, 2016 | 25 | Dec 8, 2016 | 45 |
| -20.84% | Dec 14, 2016 | 47 | Feb 23, 2017 | 11 | Mar 10, 2017 | 58 |
| -9.06% | Sep 12, 2016 | 5 | Sep 19, 2016 | 6 | Sep 27, 2016 | 11 |
| -4.64% | Mar 20, 2017 | 2 | Mar 22, 2017 | 3 | Mar 27, 2017 | 5 |
| -4.49% | Dec 9, 2016 | 1 | Dec 12, 2016 | 2 | Dec 14, 2016 | 3 |
| -3.46% | Mar 30, 2016 | 2 | Apr 1, 2016 | 3 | Apr 6, 2016 | 5 |
| -3.16% | Mar 23, 2016 | 2 | Mar 28, 2016 | 1 | Mar 29, 2016 | 3 |
| -2.62% | Apr 6, 2016 | 3 | Apr 11, 2016 | 2 | Apr 13, 2016 | 5 |
| -1.76% | Sep 28, 2016 | 1 | Sep 29, 2016 | 4 | Oct 5, 2016 | 5 |